{
    "organizations": [],
    "uuid": "09b4f1483dfeb51818a6661514eab09ece1a470f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-esperites-cell-factory-receives-eu/brief-esperites-cell-factory-receives-european-funding-for-2nd-generation-evs-drug-for-treatment-of-stroke-idUSFWN1SA0K5",
    "ord_in_thread": 0,
    "title": "Esperite's Cell Factory Receives European Funding For 2nd Generation EVS Drug For Treatment Of Stroke",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - ESPERITE NV:\n* ESPERITEâ€™S CELL FACTORY RECEIVED EUROPEAN FUNDING TO DEVELOP 2ND GENERATION EVS DRUG FOR TREATMENT OF STROKE Source text for Eikon: (Gdynia Newsroom)\nOur ",
    "published": "2018-05-03T17:39:00.000+03:00",
    "crawled": "2018-05-04T16:50:06.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "esperite",
        "nv",
        "esperite",
        "cell",
        "factory",
        "received",
        "european",
        "funding",
        "develop",
        "2nd",
        "generation",
        "ev",
        "drug",
        "treatment",
        "stroke",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}